임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 2상모집 예정· Gastrointestinal NeoplasmsA Study of Velzatinib in Participants With Metastatic and/or Unresectable GIST After Imatinib, Sunitinib, Regorafenib, and Pimitespib
리드: GSK
- 2상모집 예정· Malaria, FalciparumA Phase 2A Study of a Novel Antimalarial Pyrrolidinamide in Adult Patients With Uncomplicated P. Falciparum Malaria
리드: GSK
- 2상모집 중· Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaA Comprehensive Multiomic Biomarker Evaluation Across Two Single-arm Cohorts to Elucidate Mechanisms of Response and Resistance in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC)
협력: GSK
- 2상모집 예정· Locally Advanced Rectal Cancer (LARC)XELOX Plus DoSTARlimab Versus XELOX Alone as Consolidation Treatment After Standard Chemoradiation in pMMR/MSS or MSI-Low Locally Advanced Rectal Cancer (LARC) Patients
협력: GSK
- 2상모집 예정· DiarrhoeaLong-Term Immunogenicity of the altSonflex1-2-3 Shigella Vaccine in African Children
리드: GSK
- 2상모집 중· Respiratory Syncytial Virus (RSV)Immunogenicity of RSVPreF3 Vaccine in Immunocompromised Persons
협력: GSK
- 2상모집 중· BronchiectasisA Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
리드: GSK
- 2상모집 중단 (진행 중)· Influenza, HumanA Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above
리드: GSK
- 2상모집 예정· MMRd/MSI-H Stage II-III Endometrial CancerClinical Trial to Assess the Efficacy of Dostarlimab as Neoadjuvant Therapy in Patients With MMRd/MSI-H Stage II-III Endometrial Cancer
협력: GSK
- 2상모집 예정· Endometrial CancerpReOperative Dostarlimab and Novel Therapies in EndOmetrial Cancer
협력: GSK
- 2상모집 중· Alzheimer's DiseaseOpen-label Extension Study in Participants With Early Alzheimer's Disease
리드: GSK
- 2상모집 중· Respiratory Syncytial Virus InfectionsA Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant
리드: GSK
- 2상모집 중· Myelodysplastic SyndromesA Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome
리드: GSK
- 2상모집 중· Pancreatic Adenocarcinoma MetastaticMaintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy
협력: BMS, GSK
- 2상모집 중· Metabolic Dysfunction-Associated SteatohepatitisA Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
리드: GSK
- 2상모집 중· Primary MyelofibrosisStudy of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
리드: GSK
- 2상모집 중· Pancreas NeoplasmsDOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer
협력: GSK
- 2상모집 중단 (진행 중)· Chronic Hepatitis B Virus InfectionA Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)
리드: GSK
- 2상모집 중단 (진행 중)· Neoplasms, RectalA Study of Dostarlimab in Participants With Untreated Locally Advanced Rectal Cancer in China
리드: GSK
- 2상모집 중단 (진행 중)· Plasma Cell MyelomaBelantamab Mafodotin and Lenalidomide for the Treatment of Multiple Myeloma in Patients With Minimal Residual Disease Positive After Stem Cell Transplant
협력: GSK
- 2상모집 중· Endometrial Cancer Stage ISATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr)
협력: GSK
- 2상모집 중· Pancreatic AdenocarcinomaDostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI
협력: GSK
- 2상모집 중· Relapsed CancerIsatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma
협력: GSK, 사노피
- 2상모집 중· Pulmonary TuberculosisPlatform Assessing Regimens and Durations In a Global Multisite Consortium for TB
협력: GSK, 얀센(J&J)
- 2상모집 중· SCLC,Extensive StageNiraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC
협력: GSK
- 2상모집 중단 (진행 중)· Alzheimer's DiseaseEfficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease
리드: GSK
- 2상모집 중· Multiple MyelomaStudy of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma
협력: 암젠, GSK
- 2상모집 중단 (진행 중)· Neoplasms, RectalA Study of Dostarlimab in Untreated dMMR/MSI-H Locally Advanced Rectal Cancer
리드: GSK
- 2상모집 중단 (진행 중)· Nonalcoholic Fatty Liver DiseasePhase 2b Study of GSK4532990 in Adults With NASH
리드: GSK
- 2상모집 중· Penile CarcinomaStudy of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma
협력: GSK
- 2상모집 중단 (진행 중)· Lung Cancer, Non-Small CellA Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer
리드: GSK
- 2상모집 중단 (진행 중)· Sarcoma,Soft TissueA Study of Niraparib in People With Soft Tissue Sarcoma Who Have Changes in Their Tumor DNA
협력: GSK
- 2상모집 중· Plasma Cell MyelomaBelantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma
협력: GSK
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.